Format
Items per page
Sort by

Send to:

Choose Destination

Links from PubMed

Items: 1 to 20 of 189

1.

Myocardial damage in patients with sarcoidosis and preserved left ventricular systolic function: an observational study.

Patel AR, Klein MR, Chandra S, Spencer KT, Decara JM, Lang RM, Burke MC, Garrity ER, Hogarth DK, Archer SL, Sweiss NJ, Beshai JF.

Eur J Heart Fail. 2011 Nov;13(11):1231-7. doi: 10.1093/eurjhf/hfr099. Epub 2011 Aug 2.

2.

CMR imaging predicts death and other adverse events in suspected cardiac sarcoidosis.

Greulich S, Deluigi CC, Gloekler S, Wahl A, Zürn C, Kramer U, Nothnagel D, Bültel H, Schumm J, Grün S, Ong P, Wagner A, Schneider S, Nassenstein K, Gawaz M, Sechtem U, Bruder O, Mahrholdt H.

JACC Cardiovasc Imaging. 2013 Apr;6(4):501-11. doi: 10.1016/j.jcmg.2012.10.021. Epub 2013 Mar 14.

3.

Late gadolinium enhancement in cardiac sarcoidosis: characteristic magnetic resonance findings and relationship with left ventricular function.

Watanabe E, Kimura F, Nakajima T, Hiroe M, Kasai Y, Nagata M, Kawana M, Hagiwara N.

J Thorac Imaging. 2013 Jan;28(1):60-6. doi: 10.1097/RTI.0b013e3182761830.

PMID:
23249970
4.

Conductive channels identified with contrast-enhanced MR imaging predict ventricular tachycardia in systolic heart failure.

Lin LY, Su MY, Chen JJ, Lai LP, Hwang JJ, Tseng CD, Chen YS, Yu HY, Tseng WY, Lin JL.

JACC Cardiovasc Imaging. 2013 Nov;6(11):1152-9. doi: 10.1016/j.jcmg.2013.05.017.

5.

Late gadolinium enhancement CMR in patients with tachycardia-induced cardiomyopathy caused by idiopathic ventricular arrhythmias.

Hasdemir C, Yuksel A, Camli D, Kartal Y, Simsek E, Musayev O, Isayev E, Aydin M, Can LH.

Pacing Clin Electrophysiol. 2012 Apr;35(4):465-70. doi: 10.1111/j.1540-8159.2011.03324.x. Epub 2012 Feb 3.

PMID:
22303908
6.

Redefinition of uremic cardiomyopathy by contrast-enhanced cardiac magnetic resonance imaging.

Mark PB, Johnston N, Groenning BA, Foster JE, Blyth KG, Martin TN, Steedman T, Dargie HJ, Jardine AG.

Kidney Int. 2006 May;69(10):1839-45.

PMID:
16508657
7.

Quantifying late gadolinium enhancement on CMR provides additional prognostic information in early risk-stratification of nonischemic cardiomyopathy: a cohort study.

Pöyhönen P, Kivistö S, Holmström M, Hänninen H.

BMC Cardiovasc Disord. 2014 Aug 27;14:110. doi: 10.1186/1471-2261-14-110.

8.

Myocardial fibrosis in isolated left ventricular non-compaction and its relation to disease severity.

Nucifora G, Aquaro GD, Pingitore A, Masci PG, Lombardi M.

Eur J Heart Fail. 2011 Feb;13(2):170-6. doi: 10.1093/eurjhf/hfq222. Epub 2011 Jan 4.

9.

Left ventricular geometric remodeling in relation to non-ischemic scar pattern on cardiac magnetic resonance imaging.

Kim J, Kochav JD, Gurevich S, Afroz A, Petashnick M, Volo S, Diaz B, Okin PM, Horn E, Devereux RB, Weinsaft JW.

Int J Cardiovasc Imaging. 2014 Dec;30(8):1559-67. doi: 10.1007/s10554-014-0487-8. Epub 2014 Jul 10.

10.

Magnetic resonance imaging for identifying patients with cardiac sarcoidosis and preserved or mildly reduced left ventricular function at risk of ventricular arrhythmias.

Crawford T, Mueller G, Sarsam S, Prasitdumrong H, Chaiyen N, Gu X, Schuller J, Kron J, Nour KA, Cheng A, Ji SY, Feinstein S, Gupta S, Ilg K, Sinno M, Abu-Hashish S, Al-Mallah M, Sauer WH, Ellenbogen K, Morady F, Bogun F.

Circ Arrhythm Electrophysiol. 2014 Dec;7(6):1109-15. doi: 10.1161/CIRCEP.113.000156. Epub 2014 Sep 29.

11.

Correlation of late gadolinium enhancement MRI and quantitative T2 measurement in cardiac sarcoidosis.

Yang Y, Safka K, Graham JJ, Roifman I, Zia MI, Wright GA, Balter M, Dick AJ, Connelly KA.

J Magn Reson Imaging. 2014 Mar;39(3):609-16. doi: 10.1002/jmri.24196. Epub 2013 May 29.

PMID:
23720077
12.

Clinical Characteristics of Late Gadolinium Enhancement in Patients with Cardiac Sarcoidosis.

Matsumoto K, Ehara S, Sakaguchi M, Otsuka K, Hasegawa T, Shimada K, Yoshiyama M.

Osaka City Med J. 2015 Jun;61(1):9-17.

PMID:
26434101
13.

Cardiac magnetic resonance imaging predicts recovery of left ventricular function in acute onset cardiomyopathy.

McLellan AJ, McKenzie SC, Taylor AJ.

Heart Lung Circ. 2012 Jan;21(1):30-5. doi: 10.1016/j.hlc.2011.09.005. Epub 2011 Nov 3.

PMID:
22055931
14.

Prognosis of Myocardial Damage in Sarcoidosis Patients With Preserved Left Ventricular Ejection Fraction: Risk Stratification Using Cardiovascular Magnetic Resonance.

Murtagh G, Laffin LJ, Beshai JF, Maffessanti F, Bonham CA, Patel AV, Yu Z, Addetia K, Mor-Avi V, Moss JD, Hogarth DK, Sweiss NJ, Lang RM, Patel AR.

Circ Cardiovasc Imaging. 2016 Jan;9(1):e003738. doi: 10.1161/CIRCIMAGING.115.003738.

15.

Cardiac positron emission tomography enhances prognostic assessments of patients with suspected cardiac sarcoidosis.

Blankstein R, Osborne M, Naya M, Waller A, Kim CK, Murthy VL, Kazemian P, Kwong RY, Tokuda M, Skali H, Padera R, Hainer J, Stevenson WG, Dorbala S, Di Carli MF.

J Am Coll Cardiol. 2014 Feb 4;63(4):329-36. doi: 10.1016/j.jacc.2013.09.022. Epub 2013 Oct 16.

16.

Cardiovascular magnetic resonance of cardiomyopathy in limb girdle muscular dystrophy 2B and 2I.

Rosales XQ, Moser SJ, Tran T, McCarthy B, Dunn N, Habib P, Simonetti OP, Mendell JR, Raman SV.

J Cardiovasc Magn Reson. 2011 Aug 4;13:39. doi: 10.1186/1532-429X-13-39.

17.

Extensive late gadolinium enhancement on cardiovascular magnetic resonance predicts adverse outcomes and lack of improvement in LV function after steroid therapy in cardiac sarcoidosis.

Ise T, Hasegawa T, Morita Y, Yamada N, Funada A, Takahama H, Amaki M, Kanzaki H, Okamura H, Kamakura S, Shimizu W, Anzai T, Kitakaze M.

Heart. 2014 Aug;100(15):1165-72. doi: 10.1136/heartjnl-2013-305187. Epub 2014 May 14.

PMID:
24829369
18.

Prevalence and distribution of late gadolinium enhancement in a large population of patients with Duchenne muscular dystrophy: effect of age and left ventricular systolic function.

Hor KN, Taylor MD, Al-Khalidi HR, Cripe LH, Raman SV, Jefferies JL, O'Donnell R, Benson DW, Mazur W.

J Cardiovasc Magn Reson. 2013 Dec 21;15:107. doi: 10.1186/1532-429X-15-107.

19.

[Clinical significance of late gadolinium enhancement on cardiovascular magnetic resonance in patients with hypertrophic cardiomyopathy].

Dumont CA, Monserrat L, Soler R, Rodríguez E, Fernández X, Peteiro J, Bouzas B, Piñón P, Castro-Beiras A.

Rev Esp Cardiol. 2007 Jan;60(1):15-23. Spanish.

20.

Impact of unrecognized myocardial scar detected by cardiac magnetic resonance imaging on event-free survival in patients presenting with signs or symptoms of coronary artery disease.

Kwong RY, Chan AK, Brown KA, Chan CW, Reynolds HG, Tsang S, Davis RB.

Circulation. 2006 Jun 13;113(23):2733-43. Epub 2006 Jun 5. Erratum in: Circulation. 2006 Aug 22;114(8):e365.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk